It has been reported that drug administration induces changes in Treg function, i.e. release of immunosuppressive mechanisms, increased CD8+ T intratumoral infiltration and activation of CD8+ T in the same liver cancer model (Hepa1-6) [18]. This evidence concerns the gene CD8A and liver cancer.